https://www.cencora.com/resources/pharma/how-to-avoid-the-5-most-relevant-inspection-findings-related-to-the-qppv
Webinar: How to avoid the 5 most relevant inspection findings related to the QPPV | Cencora
Required by the European Union, the Qualified Person Responsible for Pharmacovigilance (QPPV) is critical to product compliance and marketing authorization in...
how tomost relevantwebinaravoidinspection
https://www.cencora.com/about/history
History | A legacy in innovation | Cencora
Explore our rich history of progress and excellence. Witness our evolution from AmerisourceBergen to Cencora, shaping a new era of healthcare.
historylegacyinnovationcencora
https://www.cencora.com/
Creating healthier futures | Cencora
We are Cencora. Transforming from AmerisourceBergen after a century of service, we are uniting globally for exceptional customer and patient care.
creatingfuturescencora
https://www.cencora.com/our-capabilities/commercialization-support
Pharmaceutical Commercialization Support Services | Cencora
Accelerate product launch success, reduce risk, and optimize market access strategies with Cencora’s global commercialization solutions. Learn more today!
support servicespharmaceuticalcommercializationcencora
https://www.cencora.com/newsroom/cencora-announces-financial-leadership-transition
Cencora announces financial leadership transition | Cencora
Cencora announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026.
leadership transitioncencoraannouncesfinancial